Commentary

The Year in Review, A Look Ahead at 2019

Deepak L. Bhatt, MD
Deepak L. Bhatt

Overall, 2018 was a terrific year for intervention. There were several key advances that I think will continue to play out and change CV practice throughout 2019.

One such advance is transcatheter mitral valve repair. With the recently reported COAPT trial showing improved mortality in select patients with secondary mitral regurgitation, the field of structural heart intervention has again been transformed. I anticipate growing adoption of transcatheter mitral valve repair in carefully selected patients. In 2019, I expect not only further refinement of percutaneous mitral valve repair, but also further advances in percutaneous tricuspid valve repair. In this issue, Cardiology Today’s Intervention interviews a variety of experts about the current state and future of mitral valve repair.

Other developments from 2018 that I believe will spill over into 2019 include the growing database on fractional flow reserve and instantaneous wave-free ratio. I expect these invasive assessments of lesion severity to become much more commonplace. I also anticipate that advances in lower-extremity intervention will continue to grow with assessment of novel technologies and techniques. Both diagnostic and therapeutic interventions for HF are also likely to be quite popular in 2019.

Many of the topics I have highlighted above are, in fact, exactly what the Cardiology Today’s Intervention Editorial Board voted as the Top Trends of 2019. We will be covering these topics and more in the year to come. Cardiology Today’s Intervention is asking our readers: What are your Top Trends of 2019? Email the Editors at intervention@healio.com or search the title on Healio.com/Intervention and comment online.

Deepak L. Bhatt, MD
Deepak L. Bhatt

Overall, 2018 was a terrific year for intervention. There were several key advances that I think will continue to play out and change CV practice throughout 2019.

One such advance is transcatheter mitral valve repair. With the recently reported COAPT trial showing improved mortality in select patients with secondary mitral regurgitation, the field of structural heart intervention has again been transformed. I anticipate growing adoption of transcatheter mitral valve repair in carefully selected patients. In 2019, I expect not only further refinement of percutaneous mitral valve repair, but also further advances in percutaneous tricuspid valve repair. In this issue, Cardiology Today’s Intervention interviews a variety of experts about the current state and future of mitral valve repair.

Other developments from 2018 that I believe will spill over into 2019 include the growing database on fractional flow reserve and instantaneous wave-free ratio. I expect these invasive assessments of lesion severity to become much more commonplace. I also anticipate that advances in lower-extremity intervention will continue to grow with assessment of novel technologies and techniques. Both diagnostic and therapeutic interventions for HF are also likely to be quite popular in 2019.

Many of the topics I have highlighted above are, in fact, exactly what the Cardiology Today’s Intervention Editorial Board voted as the Top Trends of 2019. We will be covering these topics and more in the year to come. Cardiology Today’s Intervention is asking our readers: What are your Top Trends of 2019? Email the Editors at intervention@healio.com or search the title on Healio.com/Intervention and comment online.